Cocoon Biotech Inc.
Biodegradable polymers and bio-based materials as petrochemical alternatives
- Sector
- Materials
- Headquarters
- Mansfield, MA
- Founded
- 2013
- Latest Form D
- $385K, Dec 2021
- Total capital
- $4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4M
- 5 Form D · last Dec 2021
- 58 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 34 pending · first 2023
- Rank in peer group#42 of 369
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$385K
- Private capital raisedForm D · SEC · 4th filing$865K
- Private capital raisedForm D · SEC · 3rd filing$755K
- Private capital raisedForm D · SEC · 2nd filing$1.8M
- Private capital raisedForm D · SEC · 1st filing$200K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 369 peers
Line = medianMaterials · Material
- Granted patents#42 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ailis Tweed-KentExecutive Officer, DirectorNamed in SEC Form D filings
- Annalisa JenkinsDirectorNamed in SEC Form D filings
- Charles KoppelDirectorNamed in SEC Form D filings
- Grace ColonDirectorNamed in SEC Form D filings
- Mary ThistleDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 40- GrantedSilk-Based Products, Formulations, and Methods of UseUSPTOUS 12,703,725
- PendingSilk-based Product Formulations And Methods Of UseUSPTOApplication 19283673
- PendingMethods Of Reducing The Signs Or Symptoms Of Dermal Disorders With Topically Applied Silk FibroinUSPTOApplication 18862286
Show all 40 patent records
- Silk-Based Products, Formulations, and Methods of UseAug 11, 2026 · US 12,703,725Granted
- Silk-based Product Formulations And Methods Of UseJun 11, 2026 · Application 19283673Pending
- Methods Of Reducing The Signs Or Symptoms Of Dermal Disorders With Topically Applied Silk FibroinOct 2, 2025 · Application 18862286Pending
- Silk-based Product Formulations And Methods Of UseSep 2, 2025 · US 12,403,177Granted
- Methods Of Making Stable Silk Fibroin FormulationsDec 10, 2024 · US 12,161,693Granted
- Silk-Based Products, Formulations, and Methods of UseOct 24, 2024 · Application 17615737Pending
- Methods For Reducing Impurities In Silk Fibroin PreparationsSep 12, 2024 · Application 18666032Pending
- Methods For Reducing Impurities In Silk Fibroin PreparationsJul 2, 2024 · US 12,024,538Granted
- Ocular Applications Of Silk-based ProductsOct 3, 2023 · US 11,771,769Granted
- Silk-based Product Formulations And Methods Of UseApr 25, 2023 · US 11,633,455Granted
- Ocular Applications Of Silk-based ProductsAug 5, 2021 · Application 16762544Pending
- Silk-based Products And Methods Of UseMay 13, 2021 · Application 16762547Pending
- Compositions Including Benzenesulfonamide-containing Non-steroidal Anti-inflammatory Drugs, Silk Fibroin, And A Gelling Agent And Uses ThereofFeb 7, 2019 · Application 16077078Pending
- Silk-based Product Formulations And Methods Of UseApplication PCTUS2019035306Pending
- Silk-based Product Formulations And Methods Of UseApplication 62856936Pending
- Silk-based Products And Methods Of UseApplication PCTUS2018059996Pending
- Ocular Applications Of Silk-based ProductsApplication PCTUS2018059998Pending
- Silk-based Products For Ocular LubricationApplication 62757984Pending
- Silk-based Product Formulations And Methods Of UseApplication 62757995Pending
- Silk-based Product Formulations And Methods Of UseApplication 62717025Pending
- Silk-based Products For Ocular LubricationApplication 62680376Pending
- Ocular Silk-based Products And Methods Of UseApplication 62680371Pending
- Silk-based Products And Methods Of UseApplication 62680386Pending
- Silk-based Products And Methods Of UseApplication 62659213Pending
- Ocular Silk-based Products And Methods Of UseApplication 62659209Pending
- Manufacture And Uses Of Silk FibroinApplication 62584153Pending
- Compositions Including Benzenesulfonamide-containing Non-steroidal Anti-inflammatory Drugs And Uses ThereofApplication PCTUS2017017535Pending
- Formulations Containing Biological Agents and Methods of UseApplication 63872047Pending
- Gels Including Benzenesulfonamide-containing Non-steroidal Anti-inflammatory Drugs And Uses ThereofApplication 62329131Pending
- Formulations Containing Biological Agents and Methods of UseApplication 63737287Pending
- Methods For Reducing Impurities In Silk Fibroin PreparationsApplication PCTUS2023020655Pending
- Methods Of Reducing The Signs Or Symptoms Of Dermal Disorders With Topically Applied Silk FibroinApplication PCTUS2023020349Pending
- Methods For Reducing Impurities In Silk Fibroin PreparationsApplication 63420160Pending
- Methods Of Reducing The Signs Or Symptoms Of Dermal Disorders With Topically Applied Silk FibroinApplication 63337325Pending
- Methods Of Making Stable Silk Fibroin FormulationsApplication PCTUS2022024731Pending
- Formulations Containing Processed SilkApplication 63175024Pending
- Silk-based Products, Formulations, And Methods Of UseApplication PCTUS2020036073Pending
- Silk-based Products, Formulations, And Methods Of UseApplication 62944534Pending
- Silk-based Products, Formulations, And Methods Of UseApplication 62926855Pending
- Silk-based Textiles And Methods Of UseApplication 62893834Pending
Related companies, and why
- Tectonic Audio Labs Inc.Similar federal contract value in Materials · null in contracts
- Intrinsiq Materials, Inc.Similar federal contract value in Materials · null in contracts
- Oceanix USA Inc.Similar federal contract value in Materials · null in contracts
- INTEMATIX CorpSimilar federal contract value in Materials · null in contracts
- Veloxint CorpSimilar federal contract value in Materials · null in contracts
- EKA SOLUTIONS, INC.Similar federal contract value in Materials · null in contracts
Regulatory activity · Materials
- Eliminating Regulations Establishing Fellowships in Laboratory Standardization and Testing for Foreign CitizensNational Institute of Standards and Technology
- Eliminating Obsolete Marking Requirements for Toy, Look-Alike, and Imitation FirearmsNational Institute of Standards and Technology
- Eliminating Obsolete Regulations Related to the Advanced Technology Program and the Technology Innovation ProgramNational Institute of Standards and Technology
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .